Sign-up   Forgot your password?
 
Home Page  Türkçe  Contact  

       [ ]

  News
 

Jan 4, 2017

Transperancy International report on Corruption in the Pharmaceutical Sector..

You can read the full report clicking from here


According to the report four overarching challenges derived from structural issues and anti-corruption policies across the selected activities of the value chain have been identified. These are:

  •  A lack of objective data and understanding of corruption inhibited by environmental context, the complexity of issues in the sector and policy makers not viewing corruption as an issue.

  •  A weak legislative and regulatory framework because of poor investment, a lack of oversight and national regulatory frameworks that are often decentralised and reliant on self-regulation for key decision-point.

  •  The potential for undue influence from companies due to a high degree of autonomy over key decision points and unparalleled resources, on policy and regulation so profit maximisation goes beyond ethical norms and negatively impacts health outcomes and public health objectives.

  •  A lack of leadership committed to anti-corruption efforts from all actors. National leaders often only implement reforms after a crisis, with their inaction regularly hindering other actors. 

« Back

Clinical Research Association © 2006-2007 PLEKSUS